PRMT3 and cancer: We also found a negative correlation between PRMT3 expression and CD8+ T cell infiltration in immunotherapy-sensitive cancer types such as skin cutaneous melanoma (SKCM) and clear cell renal carcinoma (KIRC) (Supplementary Fig. 15).